HARROW, INC. — Director's Dealing 2019

Nov 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2019-11-22

Reporting Person: BAUM MARK L (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-22	Common Stock	X	156000	$1.79	Acquired	598126	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-22	Purchase Warrant	$1.79	X	156000	Disposed	2019-12-23	Common Stock (156000)	Direct

Footnotes

F1: Total number of shares beneficially held by the Four Tree Trust dated June 3, 2019 (the "Four Tree Trust"), a trust through which Mr. Baum has voting and investment control over the securities. Mr. Baum, individually, and the Beadore Trust dated March 20, 2015 (the "Beadore Trust") assigned 442,126 shares of the Company's common stock to the Four Tree Trust.

F2: On November 22, 2019, the Beadore Trust assigned the Purchase Warrants to the Four Tree Trust.